Inventor · disambiguated record
David Moore Glover
Also filed as: GLOVER DAVID · GLOVER DAVID M · GLOVER DAVID MOORE
2 granted patents·8 pending applications·21 citations·filing 1995–2022
60Inventor score
Files withCANCER REC TECH LTD3CYCLACEL LTD2CANCER RES TECH LTD1CANCER RESEARCH TECH LTD1XALUD THERAPEUTICS INC1
Top patents by PatentIndex Score
10 records- 0159US2025051412A1Dosing regimen for il-10 encoding expression constructXALUD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0258US2015047064A1INHIBITING GENE EXPRESSION WITH dsRNACANCER REC TECH LTD·Filed 2014·Application pending·0 cites
- 0358US2008221054A1Inhibiting Gene Expression with dsRNACANCER REC TECH LTD·Filed 2007·Application pending·0 cites
- 0458US2008242628A1Inhibiting Gene Expression with dsRNACANCER REC TECH LTD·Filed 2007·Application pending·0 cites
- 0555US2018355352A1INHIBITING GENE EXPRESSION WITH dsRNACANCER RESEARCH TECH LTD·Filed 2017·Application pending·0 cites
- 0653US2017096667A1INHIBITING GENE EXPRESSION WITH dsRNACANCER RES TECH LTD·Filed 2016·Application pending·0 cites
- 0751US6242201B1Identification of the P21WaF1-PCNA interaction site and therapeutic applications thereofCYCLACEL LTD·Filed 1995·Granted Jun 5, 2001·14 cites·16 claims
- 0847US6613878B1PCNA binding substanceCYCLACEL LTD·Filed 1996·Granted Sep 2, 2003·7 cites·18 claims
- 0944US2003027783A1Inhibiting gene expression with dsRNAFiled 2002·Application pending·0 cites
- 1035US2003170655A1Mus101 and homologue thereofFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Moore Glover files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →